Cargando…
Post hoc analyses of SHIFT and PARADIGM‐HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: “Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial” by Bocchi et al.
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300803/ https://www.ncbi.nlm.nih.gov/pubmed/30298996 http://dx.doi.org/10.1002/ehf2.12355 |
| _version_ | 1783381747055984640 |
|---|---|
| author | Ramires, Felix J.A. Martinez, Felipe Gómez, Efraín A. Demacq, Caroline Gimpelewicz, Claudio R. Rouleau, Jean L. Solomon, Scott D. Swedberg, Karl Zile, Michael R. Packer, Milton McMurray, John J.V. |
| author_facet | Ramires, Felix J.A. Martinez, Felipe Gómez, Efraín A. Demacq, Caroline Gimpelewicz, Claudio R. Rouleau, Jean L. Solomon, Scott D. Swedberg, Karl Zile, Michael R. Packer, Milton McMurray, John J.V. |
| author_sort | Ramires, Felix J.A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6300803 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63008032018-12-31 Post hoc analyses of SHIFT and PARADIGM‐HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: “Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial” by Bocchi et al. Ramires, Felix J.A. Martinez, Felipe Gómez, Efraín A. Demacq, Caroline Gimpelewicz, Claudio R. Rouleau, Jean L. Solomon, Scott D. Swedberg, Karl Zile, Michael R. Packer, Milton McMurray, John J.V. ESC Heart Fail Letter to the Editor John Wiley and Sons Inc. 2018-10-09 /pmc/articles/PMC6300803/ /pubmed/30298996 http://dx.doi.org/10.1002/ehf2.12355 Text en © 2018 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Letter to the Editor Ramires, Felix J.A. Martinez, Felipe Gómez, Efraín A. Demacq, Caroline Gimpelewicz, Claudio R. Rouleau, Jean L. Solomon, Scott D. Swedberg, Karl Zile, Michael R. Packer, Milton McMurray, John J.V. Post hoc analyses of SHIFT and PARADIGM‐HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: “Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial” by Bocchi et al. |
| title | Post hoc analyses of SHIFT and PARADIGM‐HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: “Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial” by Bocchi et al.
|
| title_full | Post hoc analyses of SHIFT and PARADIGM‐HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: “Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial” by Bocchi et al.
|
| title_fullStr | Post hoc analyses of SHIFT and PARADIGM‐HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: “Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial” by Bocchi et al.
|
| title_full_unstemmed | Post hoc analyses of SHIFT and PARADIGM‐HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: “Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial” by Bocchi et al.
|
| title_short | Post hoc analyses of SHIFT and PARADIGM‐HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: “Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial” by Bocchi et al.
|
| title_sort | post hoc analyses of shift and paradigm‐hf highlight the importance of chronic chagas' cardiomyopathy comment on: “safety profile and efficacy of ivabradine in heart failure due to chagas heart disease: a post hoc analysis of the shift trial” by bocchi et al. |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300803/ https://www.ncbi.nlm.nih.gov/pubmed/30298996 http://dx.doi.org/10.1002/ehf2.12355 |
| work_keys_str_mv | AT ramiresfelixja posthocanalysesofshiftandparadigmhfhighlighttheimportanceofchronicchagascardiomyopathycommentonsafetyprofileandefficacyofivabradineinheartfailureduetochagasheartdiseaseaposthocanalysisoftheshifttrialbybocchietal AT martinezfelipe posthocanalysesofshiftandparadigmhfhighlighttheimportanceofchronicchagascardiomyopathycommentonsafetyprofileandefficacyofivabradineinheartfailureduetochagasheartdiseaseaposthocanalysisoftheshifttrialbybocchietal AT gomezefraina posthocanalysesofshiftandparadigmhfhighlighttheimportanceofchronicchagascardiomyopathycommentonsafetyprofileandefficacyofivabradineinheartfailureduetochagasheartdiseaseaposthocanalysisoftheshifttrialbybocchietal AT demacqcaroline posthocanalysesofshiftandparadigmhfhighlighttheimportanceofchronicchagascardiomyopathycommentonsafetyprofileandefficacyofivabradineinheartfailureduetochagasheartdiseaseaposthocanalysisoftheshifttrialbybocchietal AT gimpelewiczclaudior posthocanalysesofshiftandparadigmhfhighlighttheimportanceofchronicchagascardiomyopathycommentonsafetyprofileandefficacyofivabradineinheartfailureduetochagasheartdiseaseaposthocanalysisoftheshifttrialbybocchietal AT rouleaujeanl posthocanalysesofshiftandparadigmhfhighlighttheimportanceofchronicchagascardiomyopathycommentonsafetyprofileandefficacyofivabradineinheartfailureduetochagasheartdiseaseaposthocanalysisoftheshifttrialbybocchietal AT solomonscottd posthocanalysesofshiftandparadigmhfhighlighttheimportanceofchronicchagascardiomyopathycommentonsafetyprofileandefficacyofivabradineinheartfailureduetochagasheartdiseaseaposthocanalysisoftheshifttrialbybocchietal AT swedbergkarl posthocanalysesofshiftandparadigmhfhighlighttheimportanceofchronicchagascardiomyopathycommentonsafetyprofileandefficacyofivabradineinheartfailureduetochagasheartdiseaseaposthocanalysisoftheshifttrialbybocchietal AT zilemichaelr posthocanalysesofshiftandparadigmhfhighlighttheimportanceofchronicchagascardiomyopathycommentonsafetyprofileandefficacyofivabradineinheartfailureduetochagasheartdiseaseaposthocanalysisoftheshifttrialbybocchietal AT packermilton posthocanalysesofshiftandparadigmhfhighlighttheimportanceofchronicchagascardiomyopathycommentonsafetyprofileandefficacyofivabradineinheartfailureduetochagasheartdiseaseaposthocanalysisoftheshifttrialbybocchietal AT mcmurrayjohnjv posthocanalysesofshiftandparadigmhfhighlighttheimportanceofchronicchagascardiomyopathycommentonsafetyprofileandefficacyofivabradineinheartfailureduetochagasheartdiseaseaposthocanalysisoftheshifttrialbybocchietal |